About us Solutions Capabilities Therapeutic Areas Resources Careers Submit an RFP EN Oncology & Hematology Excelya>Therapeutic Areas>Oncology & Hematology A highly skilled full-service CRO Due to aging populations and lifestyle changes predisposing to disease, cancers remain one on the main causes of fatalities and will continue at an estimated annual rate of 10% until 2030. This is why research in the fields of oncology and haematology demand high degrees of reliability and speed to help sponsors reduce lead time before new drugs or devices can be launched. Excelya is a highly skilled and renowned CRO in these areas. We ensure our sponsors benefit from the best methods and teams to proceed with studies matching their specific culture and expectations, while maintaining the focus on individual patients’ needs. We cover a broad range of fields, including immuno-oncology, cellular therapies, gene therapies, etc. Reducing time from discovery to market We deliver full-service clinical research by managing every stage, respecting your goals, timelines and specific culture: Clinical Trial Strategy Trial design and protocol Regulatory submissions KOL / patient recruitment Plus Phase IV / NIS non interventional studies/ IS Real-World Evidence (RWE) studies Commercial optimization Building the relevant network and team Time and accuracy are key in oncology and haematology, which is why we developed a worldwide network of experts and investigators to leverage trials carried out by top international expert boards. Our teams develop flexible approaches and adaptive methods to get as much information as possible from each trial in the shortest possible timeframe to obtain a high quality, high reliability result. CONTACT EXCELYA The highest quality CRO with the most comprehensive service coverage throughout Europe Contact Excelya 738 rue Yves Kermen 92100 Boulogne Billancourt +33 (0)1 46 20 74 50 Contact us Discover About us Solutions Capabilities Therapeutic Areas Careers Data Protection Notice Cookie Notice Legal Notice Newsletter By subscribing, you acknowledge that you have read our Data Protection Notice and that you wish to receive marketing communications from Excelya. We are social Excelya 2021. All rights reserved. EN FR Contact us Join us At Excelya, we use cookies to allow our users to navigate through our website, remember their preferences and for audience measurement. By clicking on “Agree”, we will also use cookies to track and analyze user behavior, allow interaction with social networks, and for targeted advertising. For more information, including on storage and third parties, please check ourCookie Notice Reject All Accept All Cookies Cookies Settings